(13223324), S. R. M., (22676321), A. R., (22676324), M. A. P., (22676327), E. Z. E., (22676330), M. D., (3480455), H. H., . . . (22676354), M. J. Y. A. (2025). Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.
Chicago Style (17th ed.) Citation(13223324), Seyed Reza Mousavi, et al. Demographic Information and Clinical Presentation of Victims in Phase III Non-inferiority Clinical Trial of SnaFab Compare to Razi Antivenom in Snakebites. 2025.
MLA (9th ed.) Citation(13223324), Seyed Reza Mousavi, et al. Demographic Information and Clinical Presentation of Victims in Phase III Non-inferiority Clinical Trial of SnaFab Compare to Razi Antivenom in Snakebites. 2025.
Warning: These citations may not always be 100% accurate.